Genes Influence Response to Glycemic Control as a Preventive Therapy for Cardiovascular Complications in Type 2 Diabetes
Genes play a role in how people with type 2 diabetes at high risk of cardiovascular disease risk respond to intensive glycemic control as an intervention to prevent the disease.
19-Sep-2016 12:05 PM EDT Add to Favorites
There are no established drugs to improve angiogenesis in diabetes. However, researchers at Joslin Diabetes Center now have identified a gene called CITED2 in a molecular pathway that may offer targets for drugs that treat these conditions by...
25-Aug-2016 2:05 PM EDT Add to Favorites
Researchers at Joslin Diabetes Center now have demonstrated that umbilical cells from children of obese or overweight mothers show impaired expression of key genes regulating cell energy and metabolism, compared to similar cells from babies of...
22-Aug-2016 3:05 PM EDT Add to Favorites
But some studies are showing that these reactive oxygen species (ROS) molecules sometimes can aid in maintaining health—findings now boosted by a surprising discovery from Joslin Diabetes Center researchers.
18-Aug-2016 3:05 PM EDT Add to Favorites
Dr. Jennifer Sun, Investigator in the Section of Vascular Biology, Receives RPB Physician-Scientist Award from Research to Prevent Blindness
Jennifer K. Sun, M.D., MPH, Investigator in the Section on Vascular Biology at Joslin Diabetes Center, an Ophthalmologist in Beetham Eye Institute (BEI) at Joslin Diabetes Center and Associate Professor at Harvard Medical School, has been granted an...
19-Jul-2016 3:05 PM EDT Add to Favorites
Most pregnant women with well-controlled diabetes give birth to healthy children. But their babies run much higher risks of birth defects than babies born to women without diabetes, because very early in embryonic development, the babies are exposed...
22-Jun-2016 4:05 PM EDT Add to Favorites
Overweight and Obese Type 2 Patients Show Significant Improvements with Structured Nutrition Therapy According to New Study
Researchers at Joslin Diabetes Center have announced the results of a study that may change how nutrition therapy is delivered to overweight and obese patients with type 2 diabetes.
21-Jun-2016 11:05 AM EDT Add to Favorites
Joslin Diabetes Center Announces Extended Collaboration with Sanofi for the Development of Novel Treatments for Diabetes Complications
Joslin Diabetes Center, a research and clinical affiliate of Harvard Medical School, today announced a newly signed collaboration with Sanofi (EURONEXT: SAN and NYSE: SNY) which extends their ongoing collaboration in exploring novel targets for...
9-Jun-2016 9:05 AM EDT Add to Favorites
Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies
6-Jan-2015 11:00 AM EST
Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT
13-Nov-2013 1:00 PM EST
The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT
Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT